Use of Amylin agonists to modulate triglycerides

Details for Australian Patent Application No. 2003235742 (hide)

Owner Amylin Pharmaceuticals, Inc.

Inventors Maggs, David G; Weyer, Christian; Fineman, Mark; Kolterman, Orville G

Agent Freehills

Pub. Number AU-B-2003235742

PCT Number PCT/US03/00369

PCT Pub. Number WO2003/057244

Priority 60/347,128 08.01.02 US

Filing date 8 January 2003

Wipo publication date 24 July 2003

Acceptance publication date 7 August 2008

International Classifications

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

Event Publications

4 September 2003 Application Open to Public Inspection

  Published as AU-B-2003235742

4 September 2003 Complete Application Filed

  Priority application(s): 60/347,128 08.01.02 US

7 August 2008 Application Accepted

  Published as AU-B-2003235742

4 December 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003235743-TOPICAL APPLICATION OF ALPHADFMO AND ANTI-INFLAMMATORY DRUG FOR TREATMENT OF ACTINIC KERATOSES

2003235741-Deazapurines and uses thereof